• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟疾——当今的问题。425例病例的经验。

Falciparum malaria--present day problems. An experience with 425 cases.

作者信息

Mehta S R, Naidu G, Chandar V, Singh I P, Johri S, Ahuja R C

出版信息

J Assoc Physicians India. 1989 Apr;37(4):264-7.

PMID:2693436
Abstract

Clinical details and present day problems encountered in 425 cases of falciparum malaria (PF) are reported. 10.11% had taken chloroquine prior to reporting to us. Parasitic count done in 23.05% cases lacked correlation with severity of disease. Pattern of fever varied markedly but 5.4% were afebrile throughout and presented only with bodyache and malaise. Apyrexial spell was noted in 5.64%. 28.70% had typical facial looks of anaemia and sallow complexion. Cerebral symptoms were noted in 3.05%. Other symptoms were severe headache 33.4%, pain abdomen 3.29%, gastroenteritis 5.64%, jaundice 2.58% and bronchitis in 7.50%. We encountered subconjunctival haemorrhages with purpura and/or urticaria in four cases, symptoms suggestive of shock lung in 3, pulmonary oedema in 2, severe anaemia (HB less than 4 g%) in seven pregnant ladies, extrapyramidal symptoms in follow up period in 5 and congenital malaria in 2 cases. 83.25% were cured with chloroquine and oxytetracycline. 8.47% (who deteriorated despite the above treatment) were treated with quinine for 6 days. 5.17% (with severe disease) were also given quinine as first line drug. 2.82% (unresponsive to chloroquine and oxytetracycline but with mild disease) were treated with pyrimethamine-sulphamezathine combination for 5 days. One case who did not respond to quinine was treated with quinidine. Recrudescence was seen in 3.67% of patients treated with chloroquine and oxytetracycline. There was no case with renal failure, haemolysis due to G6PD deficiency and black water fever. There was only one death (0.23%) in our series. Self-medication, haphazard therapy and the slogan "Fever may be malaria-take chloroquine" can lead to problems in falciparum malaria.

摘要

报告了425例恶性疟(PF)患者的临床细节及当前遇到的问题。10.11%的患者在前来就诊前服用过氯喹。23.05%的病例进行了寄生虫计数,但与疾病严重程度缺乏相关性。发热模式差异显著,5.4%的患者始终无发热,仅表现为身体疼痛和不适。5.64%的患者出现无热期。28.70%的患者有典型的贫血面容和面色蜡黄。3.05%的患者出现脑部症状。其他症状包括严重头痛33.4%、腹痛3.29%、肠胃炎5.64%、黄疸2.58%以及支气管炎7.50%。我们遇到4例伴有紫癜和/或荨麻疹的结膜下出血,3例有提示休克肺的症状,2例有肺水肿,7例孕妇有严重贫血(血红蛋白低于4g%),5例在随访期出现锥体外系症状,2例有先天性疟疾。83.25%的患者用氯喹和土霉素治愈。8.47%(尽管上述治疗病情仍恶化)的患者用奎宁治疗6天。5.17%(患有严重疾病)的患者也将奎宁作为一线药物使用。2.82%(对氯喹和土霉素无反应但病情较轻)的患者用乙胺嘧啶 - 磺胺甲嘧啶联合治疗5天。1例对奎宁无反应的患者用奎尼丁治疗。在接受氯喹和土霉素治疗的患者中,3.67%出现复发。没有出现肾衰竭、葡萄糖 - 6 - 磷酸脱氢酶(G6PD)缺乏导致的溶血和黑水热病例。我们的系列病例中仅有1例死亡(0.23%)。自我用药、随意治疗以及“发热可能是疟疾,服用氯喹”的口号可能会给恶性疟带来问题。

相似文献

1
Falciparum malaria--present day problems. An experience with 425 cases.恶性疟疾——当今的问题。425例病例的经验。
J Assoc Physicians India. 1989 Apr;37(4):264-7.
2
Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.巴布亚新几内亚针对恶性疟原虫、间日疟原虫和三日疟原虫的标准治疗方案的寄生虫学及临床疗效
P N G Med J. 2005 Sep-Dec;48(3-4):141-50.
3
The changed clinical spectrum of malaria due to drug resistance.由于耐药性导致的疟疾临床谱变化。
J Assoc Physicians India. 1998 Apr;46(4):360-2.
4
Plasmodium falciparum: drug-resistant malaria complicating leukemias and lymphomas in children.
Exp Parasitol. 1999 Sep;93(1):33-7. doi: 10.1006/expr.1998.4364.
5
[Chemosensitivity of Plasmodium falciparum in Sainte Marie island, east coast of Madagascar: in vivo and in vitro studies].[马达加斯加东海岸圣玛丽岛恶性疟原虫的化学敏感性:体内和体外研究]
Arch Inst Pasteur Madagascar. 2000;66(1-2):26-31.
6
Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.1990 - 1993年巴布亚新几内亚马当省恶性疟原虫疟疾对阿莫地喹、氯喹和奎宁的耐药性
P N G Med J. 1996 Mar;39(1):16-22.
7
Effect of four different types of single-dose treatment with chloroquine and with chloroquine and pyrimethamine on Plasmodium falciparum infections in a semi-immune population in northern Nigeria.在尼日利亚北部半免疫人群中,四种不同类型的氯喹单剂量治疗以及氯喹与乙胺嘧啶联合单剂量治疗对恶性疟原虫感染的影响。
Bull World Health Organ. 1972;46(1):117-22.
8
Chloroquine-resistant falciparum malaria from East Africa.来自东非的氯喹耐药恶性疟
J Trop Med Hyg. 1986 Dec;89(6):291-4.
9
Resurgence of malaria and drug resistance in plasmodium falciparum and plasmodium vivax species in Bombay.孟买恶性疟原虫和间日疟原虫物种中疟疾及耐药性的再度出现。
J Assoc Physicians India. 1995 May;43(5):336-8.
10
A combination of sulfamonomethoxine and pyrimethamine versus other drugs for the treatment of malaria.磺胺间甲氧嘧啶和乙胺嘧啶联合用药与其他药物治疗疟疾的比较。
Jpn J Exp Med. 1986 Oct;56(5):213-9.

引用本文的文献

1
The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study.疟疾感染后肝功能试验异常的动态变化:一项回顾性观察研究。
Am J Trop Med Hyg. 2018 Apr;98(4):1113-1119. doi: 10.4269/ajtmh.17-0754. Epub 2018 Feb 8.
2
Malaria: Continues to be a Scourge.疟疾:仍然是一大祸害。
Med J Armed Forces India. 2007 Apr;63(2):102-3. doi: 10.1016/S0377-1237(07)80047-5. Epub 2011 Jul 21.
3
Approach to clinical syndrome of jaundice and encephalopathy in tropics.热带地区黄疸和脑病临床综合征的诊治方法
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S116-30. doi: 10.1016/j.jceh.2014.05.007. Epub 2014 Jun 6.
4
Liver changes in severe Plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression.严重恶性疟原虫疟疾的肝脏变化:组织病理学、细胞凋亡和核因子 kappa B 的表达。
Malar J. 2014 Mar 17;13:106. doi: 10.1186/1475-2875-13-106.
5
A Rare Case Report of Fatal Fulminant Hepatic Failure in a Child due to Mixed vivax and falciparum Infection.一例因间日疟原虫和恶性疟原虫混合感染导致儿童致命性暴发性肝衰竭的罕见病例报告。
Case Rep Pediatr. 2011;2011:614054. doi: 10.1155/2011/614054. Epub 2011 Oct 19.
6
Infectious diseases and the liver.传染病与肝脏。
Clin Liver Dis. 2011 Feb;15(1):111-30. doi: 10.1016/j.cld.2010.09.002.
7
Exchange transfusion for severe falciparum malaria?重症恶性疟的换血疗法?
Infection. 1992 May-Jun;20(3):174-5. doi: 10.1007/BF01704617.